Drugs / 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily
380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05204667 | Oct 2021 → Nov 2023 | — | Angelini Pharma | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05204667 ↗ |